SOCIETY OF CARDIOLGY brought its first consensus regarding the reuse of single used devices(SUDs). The current consensus provides a crystal clear image of reuse of single used device (SUDs) in cardiovascular intervention in our time and its future for the developing world and developed world. All around the world, the intervention cardiologists have been reusing SUDs since 1970s based on the consensus of individual institute. 2 The intervention cardiologists in developing world reuse the SUDs because of inadequate financial support while others reuse SUDs to reduce pollution,save money and the practice is found be safe. 3, 4 Inadequate cleaning, deposits of sterilizing chemicals, cross infections, device failure and loss of functional integrity due to wear tear and medicolegal issues discourages such practice in some countries. 5 We shared our experience of percutaneous device closure of various congenital cardiac defects using a new occluder but sterilized supportive hardware like delivery sheath, delivery cable and device loader. During the immediate follow up of the procedure (before discharge) 2 patients had complications, one case of PBAV had moderate aortic regurgitation on echo, and 1 patient of ASD device closure had CVA but those were not issues related to the reuse of sterilized supportive hardware like delivery sheath, delivery cable and loaders etc. A comparative study using new device and new supportive hardware vs new device and sterilized hardware would have provided a better picture. There were 2(2.08%) deaths in the immediate follow up period (before discharge), of them 1 patient was attempted for PDA ductal stenting and the other had undergone PBAV. The follow up of patients post discharge is 1 month without any complications not particularly related reuse of SUDs. There were no evidences of infective endocarditis. The financial support for catheter based intervention from Odisha state treatment fund (OSTF) or Aarogyasri Health Care Trust is inadequate which are the affiliating institutes linked to this study. 7, 8 The cost of only a new occluder (not FDA approved) for atrial septal defect, patent ductus arteriosus and ventricular defect was approximately sixty thousand and the cost of FDA approved devices like Amplatzer devices were still higher. The procedural charge was kept only five to six thousand using sterilized supportive hardware. The financial support provided by various government schemes is only six thousand. Therefore, with the limited financial support from government, it was not even possible to perform device(new) closure using sterilized supportive hardware. When everything is taken new including the cost of each device closure crosses 150,000 rupees. This higher cost was afforded by less than 10% of patients. The hardware used in these cases were properly sterilized using the consensus by ISC,1997 and Contents lists available at ScienceDirect Indian Heart Journal j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / i h j 2017. 1, 6 for other patients after sterilizing. Because of lack of adequate financial support, some procedure like percutaneous mitral valvotomy was not possible during study period for the patients for whom Aarogyasri or OSTF was funding . In the other hand, to reduce pollution, adherence to the rule of "three R" (reduce, recycle and reuse) is required for sustainable development. 9 The safety of reuse of devices, catheters and sheaths used in different cardiovascular intervention is proved in several studies. 5 The current consensus on reuse of devices in cardiovascular would decisively help cardiovascular practicenor from either world i.e. the one from limited resources by recycling and reusing SUDs and the other who practice in affluence countries by reducing pollution. Even though we had the constraint of equipment and finance, our study highlights the successful and safety recycling of devices and accessories used in cardiovascular intervention in congenital heart diseases.
